Skip to main content
CLGN
NASDAQ Industrial Applications And Services

Loewenbaum Group Cuts Stake to 24.99% After Removing Three Members

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$0.312
Mkt Cap
$5.892M
52W Low
$0.27
52W High
$3.18
52W Position info
15% above low
Off High info
90% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

CLGN sits 15% above its 52-week low of $0.27.

Summary

The Loewenbaum family group reduced its CollPlant stake to 24.99% after removing three members from its reporting group, and transferred funds for Series B warrant exercise without actually exercising them.


Key Events · Ownership and Investor Activity · CLGN

  • Group Stake Reduced to 24.99%

    The Loewenbaum group removed Nachum Shamir, Patrick Chalmers, and Reginald J. Hargrove from its reporting group, reducing aggregate beneficial ownership from 33.0% to 24.99%.

  • Series B Warrant Funds Transferred

    The Loewenbaum 1992 Trust transferred funds equal to the aggregate exercise price of the Series B Warrants to the company on August 20, 2026, but no warrants were exercised; funds are held in abeyance.

  • Beneficial Ownership Limitation Maintained

    The group's stake is capped at 24.99% by the beneficial ownership limitation on warrant exercise, and the removal of members keeps the group below this threshold.

  • Prior Stake Increases

    The group had previously increased its stake from 18.6% to 33.0% through warrant exercises in July 2026, as disclosed in prior 13D/A filings.


Analysis · CLGN · Industrial Applications And Services

The Loewenbaum family group has removed Nachum Shamir, Patrick Chalmers, and Reginald J. Hargrove from its reporting group, reducing its aggregate beneficial ownership from 33.0% to 24.99%. This is a material change in the group's composition and stake, though the group remains the largest shareholder. Separately, the Loewenbaum 1992 Trust transferred funds to the company for the Series B warrant exercise price but has not exercised the warrants, leaving the funds in abeyance. This suggests the group is positioning to maintain its stake below the 24.99% beneficial ownership limitation while retaining the ability to exercise warrants later.

How filings like this one have moved

In the 30 days to Nov 1, 2026, 32.4% of the 1981 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CLGN was trading at $0.31 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $5.9M. The 52-week trading range was $0.27 to $3.18. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CLGN - Latest Insights

CLGN
Oct 29, 2026, 12:06 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $3.95
Real-time Price: $4.21 info
Change: +$0.263 (+7%) info
Market Cap: $7.819M info
CLGN
Oct 15, 2026, 6:04 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $4.13
Real-time Price: $4.21 info
Change: +$0.083 (+2%) info
Market Cap: $7.819M info
CLGN
Oct 09, 2026, 5:15 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $3.51
Real-time Price: $4.21 info
Change: +$0.703 (+20%) info
Market Cap: $7.819M info
CLGN
Sep 30, 2026, 5:27 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $3.78
Real-time Price: $4.21 info
Change: +$0.433 (+11%) info
Market Cap: $7.819M info
CLGN
Sep 30, 2026, 5:20 PM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $3.78
Real-time Price: $4.21 info
Change: +$0.433 (+11%) info
Market Cap: $7.819M info